Analysis of topoisomerase mutations in fluoroquinolone-resistant and -susceptible Campylobacter jejuni strains isolated in Senegal
- PMID: 17224260
- DOI: 10.1016/j.ijantimicag.2006.11.012
Analysis of topoisomerase mutations in fluoroquinolone-resistant and -susceptible Campylobacter jejuni strains isolated in Senegal
Abstract
In this study, topoisomerase mutations in ciprofloxacin-resistant and -susceptible Campylobacter jejuni were analysed by DNA sequencing. In certain ciprofloxacin-resistant C. jejuni, the mechanism of resistance was complex. The Thr86-Ala substitution in the GyrA protein appears to play a role in increasing the minimum inhibitory concentration of nalidixic acid only. In addition, isolates with this amino acid change and those resistant to quinolones but lacking a mutation in the GyrA quinolone resistance-determining region could be derived from two different clones. Based on gyrA and gyrB polymorphisms, C. jejuni isolates from the Dakar region of Senegal appeared to be less diverse than those from other countries. Moreover, C. jejuni isolates in Senegal appeared to differ from European isolates by lack of a silent mutation at codon 120 of the gyrA gene.
Similar articles
-
Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.J Appl Microbiol. 2004;96(5):1040-7. doi: 10.1111/j.1365-2672.2004.02242.x. J Appl Microbiol. 2004. PMID: 15078520
-
Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.Pathology. 2004 Apr;36(2):166-9. doi: 10.1080/00313020410001672019. Pathology. 2004. PMID: 15203753
-
Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.Antimicrob Agents Chemother. 2005 Aug;49(8):3347-54. doi: 10.1128/AAC.49.8.3347-3354.2005. Antimicrob Agents Chemother. 2005. PMID: 16048946 Free PMC article.
-
Macrolide resistance in Campylobacter jejuni and Campylobacter coli.J Antimicrob Chemother. 2006 Aug;58(2):243-55. doi: 10.1093/jac/dkl210. Epub 2006 May 30. J Antimicrob Chemother. 2006. PMID: 16735431 Review.
-
Mechanisms of resistance to quinolones.Clin Infect Dis. 2005 Jul 15;41 Suppl 2:S120-6. doi: 10.1086/428052. Clin Infect Dis. 2005. PMID: 15942878 Review.
Cited by
-
Antimicrobial Resistance Determinants Circulating among Thermophilic Campylobacter Isolates Recovered from Broilers in Ireland Over a One-Year Period.Antibiotics (Basel). 2020 Jun 8;9(6):308. doi: 10.3390/antibiotics9060308. Antibiotics (Basel). 2020. PMID: 32521746 Free PMC article.
-
Validation of the T86I mutation in the gyrA gene as a highly reliable real time PCR target to detect Fluoroquinolone-resistant Campylobacter jejuni.BMC Infect Dis. 2020 Jul 16;20(1):518. doi: 10.1186/s12879-020-05202-4. BMC Infect Dis. 2020. PMID: 32677920 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical